Harvard Medical School (HMS) will host a two-day Dean’s Symposium on Clinical and Translational Research on April 30 and May 1. Students, trainees, and faculty who are engaged in, or are interested in, clinical and translational research will convene for the first event of this kind. The symposium will highlight the full spectrum of high-impact clinical and translational research conducted at all Harvard institutions, and HMS Dean of Clinical and Translational Research Lee Nadler will formally summarize the state of clinical and translational research at Harvard.
Day one tackles “Challenges to Successful Innovation and Translation” and features speakers Yochai Benkler, Jack N. and Lillian R. Berkman Professor of Entrepreneurial Legal Studies, Harvard Law School; Senior Associate Dean and Director of Research Srikant M. Datar, Arthur Lowes Dickinson Professor of Accounting, Harvard Business School; and George M. Whitesides, Woodford L. and Ann A. Flowers University Professor, Department of Chemistry and Chemical Biology.
Day two is split between the themes “Thought, Emotion, and the Brain” and “Medical Nanotechnology: Small Is Big.” Speakers include Randy L. Buckner, professor of psychology and of neuroscience, Department of Psychology; John Gabrieli, professor of brain and cognitive sciences, Massachusetts Institute of Technology; Christopher A. Walsh, chief of the division of genetics at Children’s Hospital Boston; David A. Weitz, Mallinckrodt Professor of Physics and of Applied Sciences, Department of Physics; Charles M. Lieber, Mark Hyman, Jr. Professor of Chemistry; and Daniel Branton, Higgins Professor of Biology Emeritus.